Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
26.85
+0.60 (2.29%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Apnimed Market Cap
Apnimed has a market cap or net worth of $1.49 billion as of September 2, 2026.
Market Cap
1.49B
Enterprise Value
1.48B
1-Year Change
n/a
Ranking
Category
Stock Price
$26.85
ChartMarket Cap Chart
Since the IPO on July 31, 2026, Apnimed's market cap has increased from $607.99M to $1.49B, an increase of 144.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.49B | 2.29% |
| Aug 31, 2026 | 1.45B | -11.65% |
| Aug 28, 2026 | 1.65B | 3.45% |
| Aug 27, 2026 | 1.59B | -2.91% |
| Aug 26, 2026 | 1.64B | 8.07% |
| Aug 25, 2026 | 1.52B | 6.79% |
| Aug 24, 2026 | 1.42B | -8.56% |
| Aug 21, 2026 | 1.55B | -1.82% |
| Aug 20, 2026 | 1.58B | -10.86% |
| Aug 19, 2026 | 1.78B | 0.69% |
| Aug 18, 2026 | 1.76B | -2.27% |
| Aug 17, 2026 | 1.80B | 2.52% |
| Aug 14, 2026 | 1.76B | 10.28% |
| Aug 13, 2026 | 1.60B | 8.05% |
| Aug 12, 2026 | 1.48B | 7.14% |
| Aug 11, 2026 | 1.38B | -10.99% |
| Aug 10, 2026 | 1.55B | 3.48% |
| Aug 7, 2026 | 1.50B | -3.16% |
| Aug 6, 2026 | 1.55B | 5.17% |
| Aug 5, 2026 | 1.47B | 3.11% |
| Aug 4, 2026 | 1.42B | 2.84% |
| Aug 3, 2026 | 1.39B | 127.89% |
| Jul 31, 2026 | 607.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.55B |
| Innoviva | 1.52B |
| LB Pharmaceuticals | 1.52B |
| Absci | 1.52B |
| Tyra Biosciences | 1.51B |
| Ascentage Pharma Group International | 1.51B |
| ArriVent BioPharma | 1.49B |
| Replimune Group | 1.48B |